Member Info for VikR

I’ve invested in 23 different companies I am playing with over a million pounds in my HL account split amongst different stocks. I don’t need to ramp anything, I just promote best practice in shares which I believe in, of which hamak is one of them. Your point is irrelevant, true believers in IMM won’t be selling any of the shares until at least 31/12/25

Hi

You may see mine posted today 19.3k I will let you know when he executes the £50k, when I brought it last week I was able to buy it in one go at 10.3p

Such is the faith he has in my advice and seen my own account go into 6 figures of blue last week. Even better that he will get a good entry price below 18p. Not sure what’s funny about making money, it’s what we are here for, well presumably you are I would think

I don’t have a target exit price as such at present, I’m already 6 figures in profit fortunately. All I want to see is the deal announced, the share price to shoot up to wherever it decides to settle albeit -

50p

75p

£1+

Everyone wins at whatever level the market decides to take it to. Once again real genuine investors do not get distracted by the DERAILERS that appear like vultures on this board. They use this same repeated tactic to try and top up at cheaper levels whilst maintaining they are shareholder empathizers and doing it for the greater good.

2025 the year of delivery and life changing money for us all.

Good morning from Sunny New York City astute investors. I managed to top up another 19k today as these levels are just an absolute bargain at the moment. Expect another breach of 18-22p in fairly short order.

To echo this sentiment and ingrain it in your mind: The CEO has literally confirmed multiple times the deal is between now and year end. Where will you find a better investment to park your money away for such a short period and such a massive return. My cousin is also on vacation with me and is awaiting his £50k business loan to clear and will be coming straight in here

Keep topping up at these prices this unilateral spike will happen sooner then you suspect

The news we were all waiting for

Lost for words apart from

Groundbreaking/amazing/one in a million opportunity

Just topped up again , orders getting filled. Numerous interviews all alluding to the same thing, people lose the faith every half an hour movement. Shocking trading behavior.

A deal will be concluded by 31/12/25

New interview

Lisa has done me the honour of letting me know before it gets officially released on further platforms tomorrow morning.

Onwards and upwards we go astute investors

https://www.youtube.com/watch?v=f4U-96wP_fA&t=321s

Not much too add as much has been explained already apart from buy and hold until the actual exponential explosive rerate on a big pharma agreement. Tim has the upper hand here by some margin to negotiate some very very favourable terms.

Load up and you shall be rewarded in abundance

Best, Vik

Still a good buy, happy to buy and hold this one, as mentioned its not a case if the news comes its a case of when it comes. Either way time in the market vs timing the market is the safer more productive action to implement

stay vested astute investors

Fantastic buy at this level got 0.76p as an entry price, took profits for IMM which made me 6 figures on Friday. AIM is on fire this quarter

Load up astute investors, these gold grades, location and team in situ is a winner destined for near term success

A very strong buy at these current levels sub 3p. Just topped up in tranches which you may see on the board in a bit around 5 mins ago

Stay vested astute investors

A solid buy and hold irrespective of whenever the news comes but it will inevitably come. One share to load up and park until the groundbreaking RNS

All the concerns have been allayed by Dr Seb et al in recent interviews. It was not just an increased dose that they discovered during these last 3 years, it was also

1.) change route of administration to IV

2.) select p140 super responders based on new findings

3.) taper steroids before administering p-140 to avoid interactions between both

This is on top discovering the direct mechanism of action which has also been independently verified by the prestigious Jackson labs in USA, link below. It is the culmination of the last 3 years of serious groundwork to give the confidence which now transpires.

Still concerned or wanting to spread fear ? Your comments are not evidence based and concerns unsubstantiated. I’m all for balanced debate but not when the opposing arguments are not constructive and have ZERO merit

Expect 18p + to be breached next week is my hypothesis

https://www.jax.org/

First on the chart list looking at the technical analysis, heading for a big reversal. A brilliant buy at what should be the floor for GSCU, will be topping up tomorrow to take advantage of the next unilateral spike up on incoming news over the next news to land

Stay vested astute investors

https://youtu.be/P0uekGdFjHM?si=uZSg5_A99g2ukJ38

Sorry my mistake stats swapped other way round -

*** underactive thyroid is way more prevalent then Graves’ disease. You will probably see 10 patients with underactive thyroid for every one 1 patient who will have Graves

To correct you here medically, Tim did not say he has Graves’ disease which causes HYPERTHYROIDISM (overactive thyroid gland)

He said he suffers from hashimoto's thyroiditis which causes HYPOTHYROIDISM (under active thyroid gland)

Graves’ disease is only served by 2 current medications as I know it. Hashmitos normally has levothyroxine as its main treatment

Numbers of patients approx with both disease (UK specific):

Overactive : Less then 0.5%

Underactive: 2% of the whole population

Both subtypes are currently served by only 3 drugs, so whatever you asked your retired biomedical friend was irrelevant to what Tim has stated. There is nothing to stop supplementing existing medical therapy with p140

to restore normal immune homeostasis and even induce remission in some and create a state of normactive thyroid.

Please refrain from posting statements which are not factual, incorrect or misleading as it is unethical on some investors here who may not be scientifically minded.

To correct you here medically, Tim did not say he has Graves’ disease which causes HYPERTHYROIDISM (overactive thyroid gland)

He said he suffers from hashimoto's thyroiditis which causes HYPOTHYROIDISM (under active thyroid gland)

Graves’ disease is only served by 2 current medications as I know it. Hashmitos normally has levothyroxine as its main treatment

Numbers of patients approx with both disease (UK specific):

Under active thyroid: Less then 0.5%

Overactive thyroid: 2% of the whole population

Both subtypes are currently served by only 3 drugs, so whatever you asked your ‘retired biomedical friend’ was irrelevant to what Tim has stated. There is nothing to stop supplementing existing medical therapy with p140

to restore normal immune homeostasis and even induce remission in some and responders and create a state of normactive thyroid.

Please refrain from posting statements which are not factual, incorrect or misleading as it is unethical on some investors here who may not be scientifically minded.

To correct you here medically, Tim did not say he has Graves’ disease which causes HYPERTHYROIDISM (overactive thyroid gland)

He said he suffers from hashimoto's thyroiditis which causes HYPOTHYROIDISM (under active thyroid gland)

Graves’ disease is only served by 2 current medications as I know it. Hashmitos normally has levothyroxine as its main treatment

Numbers of patients approx with both disease (UK specific):

Under active thyroid:

Thank you for this

For those on the Fusion antibodies telegram group I added an article there recently which was covered by the media of a charity event where we handed out a 1000 bags of household goods to the local shelter. I have now tried to make it an annual event

On another note adjacent to IMM another phenomenal UK biotech stock I am heavily invested in which will also go to triple figures before year end is the aforementioned fusion antibodies, FAB. In fact its trajectory thus far is quite similar to IMM whereby it shot up from 6p around 2/12 ago and now sits around 15/16p waiting for the next unilateral spike up. There are some good scientific insights on that board.

Either way it is an extremely proud moment for UK biotech companies leading the way for novel platforms on an international scale.

For any scientist in the know there technology is light years ahead of most competitors and that’s even without optimal.

Add in optimal and with its straight to humanisation capabilities and diverse library which can be out licensed again and again,

Fab moves away from CRO to becoming a platform licensor. The financial opportunities that await post optimal validation will be like never before